| 发明名称 |
Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer |
| 摘要 |
The present invention relates to a method of treating patients with solid tumors, leukemias, and other malignancies using a combination of zosuquidar, daunorubicin, and cytarabine. The invention is also directed to pharmaceutical formulations comprising zosuquidar, daunorubicin, and cytarabine. The formulations are particularly effective in treating relapsed Acute Myelogenous Leukemia (AML).
|
| 申请公布号 |
US2007010478(A1) |
申请公布日期 |
2007.01.11 |
| 申请号 |
US20060416829 |
申请日期 |
2006.05.03 |
| 申请人 |
SIKIC BRANIMIR;HOTH DANIEL;SOCKS DAVID;GLENN SCOTT;MARCELLETTI JOHN;WALSH MICHAEL J;MULTANI PRATIK S |
发明人 |
SIKIC BRANIMIR;HOTH DANIEL;SOCKS DAVID;GLENN SCOTT;MARCELLETTI JOHN;WALSH MICHAEL J.;MULTANI PRATIK S. |
| 分类号 |
A61K31/7072;A61K31/4709;A61K31/704 |
主分类号 |
A61K31/7072 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
